These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12539478)

  • 21. [The evaluation of cell proliferation in gliomas].
    Alkiza K; Adán B; Garibi JM; Lafuente JV
    Rev Neurol; 2000 Jan 16-31; 30(2):141-6. PubMed ID: 10730321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the labeling efficiency of BrdU, DiI and FISH labeling techniques in bone marrow stromal cells.
    Li N; Yang H; Lu L; Duan C; Zhao C; Zhao H
    Brain Res; 2008 Jun; 1215():11-9. PubMed ID: 18468584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D; Ceccarelli C; Danova M; Derenzini M
    Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2-kinase in mouse T-lymphoma cells.
    Brott DA; Alvey JD; Bleavins MR; de la Iglesia FA; Lalwani ND
    J Cell Biochem; 1993 Jul; 52(3):362-72. PubMed ID: 8103524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic morphine induces premature mitosis of proliferating cells in the adult mouse subgranular zone.
    Mandyam CD; Norris RD; Eisch AJ
    J Neurosci Res; 2004 Jun; 76(6):783-94. PubMed ID: 15160390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
    Nagashima T; Hoshino T
    No To Shinkei; 1985 Dec; 37(12):1195-201. PubMed ID: 3912000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of in vitro bromodeoxyuridine labeling of oral cancers.
    Wato M; Nishikawa T; Fujita A; Nagao Y; Tsujimoto K; Matsuoka K; Horii K; Okano H; Tanaka A
    J Osaka Dent Univ; 1993 Oct; 27(2):113-20. PubMed ID: 8182503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.
    Coltrera MD; Gown AM
    J Histochem Cytochem; 1991 Jan; 39(1):23-30. PubMed ID: 1670579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-phase arrest of nutrient deprived lung cancer cells.
    Tinnemans MM; Lenders MH; ten Velde GP; Blijham GH; Ramaekers FC; Schutte B
    Cytometry; 1995 Apr; 19(4):326-33. PubMed ID: 7796697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent segmentation of BrdU-signal leads to late detection problems in studies using BrdU as cell label or proliferation marker.
    Sauerzweig S; Baldauf K; Braun H; Reymann KG
    J Neurosci Methods; 2009 Feb; 177(1):149-59. PubMed ID: 19007815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of alpha-tocopherol on cirrhotic regeneration.
    Andiran F; Ayhan A; Tanyel FC; Abbasoğlu O; Sayek I
    J Surg Res; 2000 Apr; 89(2):184-8. PubMed ID: 10729248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
    Eldrige SR; Butterworth BE; Goldsworthy TL
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical demonstration with anti-bromodeoxyuridine monoclonal antibody in experimental meningeal carcinomatosis model.
    Huang TY; Hwang SL; Howng SL
    Kaohsiung J Med Sci; 1997 Mar; 13(3):136-40. PubMed ID: 9109299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cell kinetic effect of carcinostatic agents using BrdU and its monoclonal antibody].
    Tsuji Y; Hashimoto K; Takeda J; Kakegawa T
    Nihon Rinsho; 1992 Oct; 50(10):2381-5. PubMed ID: 1333016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication sites as revealed by double label immunofluorescence against proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) in synchronized CHO cells and vincristine-induced multinucleate cells.
    Takanari H; Yamanaka H; Mitani H; Izutsu K
    Biol Cell; 1994; 82(1):23-31. PubMed ID: 7735116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between the estimated tumor growth speed and indices of bromodeoxyuridine (BrdU) incorporation and the proliferating cell nuclear antigen (PCNA) expression in superficial bladder cancer].
    Ota T; Akaza H; Hattori K; Uchida K
    Nihon Hinyokika Gakkai Zasshi; 1997 Oct; 88(10):868-73. PubMed ID: 9388366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
    Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitoses of existing corticotrophs contribute to their proliferation in the rat pituitary during the late fetal period.
    Taniguchi Y; Kominami R; Yasutaka S; Shinohara H
    Anat Embryol (Berl); 2001 Feb; 203(2):89-93. PubMed ID: 11218062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel method to investigate kinetics of rat skin cells by means of an occlusive dressing method using bromodeoxyuridine.
    Nakano R; Tsuyama S; Murata F
    J Dermatol Sci; 1997 Jan; 14(1):54-62. PubMed ID: 9049808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.